0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Injection Drug Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-24J9050
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Oncology Injection Drug Market Insights and Forecast to 2028

Global Oncology Injection Drug Market Insights and Forecast to 2028

Code: QYRE-Auto-24J9050
Report
January 2022
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Oncology Injection Drug Market

Due to the COVID-19 pandemic, the global Oncology Injection Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Organs accounting for % of the Oncology Injection Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Lymphoma segment is altered to an % CAGR throughout this forecast period.
China Oncology Injection Drug market size is valued at US$ million in 2021, while the US and Europe Oncology Injection Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Oncology Injection Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Oncology Injection Drug include Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oncology Injection Drug Scope and Segment
Oncology Injection Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oncology Injection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other

Segment by Application

Lymphoma
Myeloma
Prostate Cancer
Other

BY COMPANY

Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Oncology Injection Drug Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Injection Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oncology Injection Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Injection Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology Injection Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology Injection Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology Injection Drug Sales by Region
2.4.1 Global Oncology Injection Drug Sales by Region (2017-2022)
2.4.2 Global Sales Oncology Injection Drug by Region (2023-2028)
2.5 Global Oncology Injection Drug Revenue by Region
2.5.1 Global Oncology Injection Drug Revenue by Region (2017-2022)
2.5.2 Global Oncology Injection Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology Injection Drug Sales by Manufacturers
3.1.1 Global Top Oncology Injection Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology Injection Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Injection Drug in 2021
3.2 Global Oncology Injection Drug Revenue by Manufacturers
3.2.1 Global Oncology Injection Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2021
3.3 Global Oncology Injection Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology Injection Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Injection Drug Sales by Type
4.1.1 Global Oncology Injection Drug Historical Sales by Type (2017-2022)
4.1.2 Global Oncology Injection Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology Injection Drug Sales Market Share by Type (2017-2028)
4.2 Global Oncology Injection Drug Revenue by Type
4.2.1 Global Oncology Injection Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology Injection Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology Injection Drug Revenue Market Share by Type (2017-2028)
4.3 Global Oncology Injection Drug Price by Type
4.3.1 Global Oncology Injection Drug Price by Type (2017-2022)
4.3.2 Global Oncology Injection Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology Injection Drug Sales by Application
5.1.1 Global Oncology Injection Drug Historical Sales by Application (2017-2022)
5.1.2 Global Oncology Injection Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology Injection Drug Sales Market Share by Application (2017-2028)
5.2 Global Oncology Injection Drug Revenue by Application
5.2.1 Global Oncology Injection Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology Injection Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology Injection Drug Revenue Market Share by Application (2017-2028)
5.3 Global Oncology Injection Drug Price by Application
5.3.1 Global Oncology Injection Drug Price by Application (2017-2022)
5.3.2 Global Oncology Injection Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology Injection Drug Market Size by Type
6.1.1 North America Oncology Injection Drug Sales by Type (2017-2028)
6.1.2 North America Oncology Injection Drug Revenue by Type (2017-2028)
6.2 North America Oncology Injection Drug Market Size by Application
6.2.1 North America Oncology Injection Drug Sales by Application (2017-2028)
6.2.2 North America Oncology Injection Drug Revenue by Application (2017-2028)
6.3 North America Oncology Injection Drug Market Size by Country
6.3.1 North America Oncology Injection Drug Sales by Country (2017-2028)
6.3.2 North America Oncology Injection Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology Injection Drug Market Size by Type
7.1.1 Europe Oncology Injection Drug Sales by Type (2017-2028)
7.1.2 Europe Oncology Injection Drug Revenue by Type (2017-2028)
7.2 Europe Oncology Injection Drug Market Size by Application
7.2.1 Europe Oncology Injection Drug Sales by Application (2017-2028)
7.2.2 Europe Oncology Injection Drug Revenue by Application (2017-2028)
7.3 Europe Oncology Injection Drug Market Size by Country
7.3.1 Europe Oncology Injection Drug Sales by Country (2017-2028)
7.3.2 Europe Oncology Injection Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology Injection Drug Market Size by Type
8.1.1 Asia Pacific Oncology Injection Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology Injection Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology Injection Drug Market Size by Application
8.2.1 Asia Pacific Oncology Injection Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology Injection Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology Injection Drug Market Size by Region
8.3.1 Asia Pacific Oncology Injection Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology Injection Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology Injection Drug Market Size by Type
9.1.1 Latin America Oncology Injection Drug Sales by Type (2017-2028)
9.1.2 Latin America Oncology Injection Drug Revenue by Type (2017-2028)
9.2 Latin America Oncology Injection Drug Market Size by Application
9.2.1 Latin America Oncology Injection Drug Sales by Application (2017-2028)
9.2.2 Latin America Oncology Injection Drug Revenue by Application (2017-2028)
9.3 Latin America Oncology Injection Drug Market Size by Country
9.3.1 Latin America Oncology Injection Drug Sales by Country (2017-2028)
9.3.2 Latin America Oncology Injection Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology Injection Drug Market Size by Type
10.1.1 Middle East and Africa Oncology Injection Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology Injection Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology Injection Drug Market Size by Application
10.2.1 Middle East and Africa Oncology Injection Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology Injection Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology Injection Drug Market Size by Country
10.3.1 Middle East and Africa Oncology Injection Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology Injection Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Overview
11.1.3 Taj Oncology Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Taj Oncology Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Taj Oncology Recent Developments
11.2 S.G. Biopharm
11.2.1 S.G. Biopharm Corporation Information
11.2.2 S.G. Biopharm Overview
11.2.3 S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 S.G. Biopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 S.G. Biopharm Recent Developments
11.3 AdvaCare
11.3.1 AdvaCare Corporation Information
11.3.2 AdvaCare Overview
11.3.3 AdvaCare Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AdvaCare Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AdvaCare Recent Developments
11.4 Merrimack
11.4.1 Merrimack Corporation Information
11.4.2 Merrimack Overview
11.4.3 Merrimack Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merrimack Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merrimack Recent Developments
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Overview
11.5.3 Celgene Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Celgene Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Celgene Recent Developments
11.6 Allos Therapeutics
11.6.1 Allos Therapeutics Corporation Information
11.6.2 Allos Therapeutics Overview
11.6.3 Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Allos Therapeutics Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allos Therapeutics Recent Developments
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Overview
11.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Pharmaceuticals Recent Developments
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genzyme Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genzyme Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Praecis Pharmaceuticals
11.10.1 Praecis Pharmaceuticals Corporation Information
11.10.2 Praecis Pharmaceuticals Overview
11.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Praecis Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Praecis Pharmaceuticals Recent Developments
11.11 Millennium Pharmaceuticals
11.11.1 Millennium Pharmaceuticals Corporation Information
11.11.2 Millennium Pharmaceuticals Overview
11.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Millennium Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Millennium Pharmaceuticals Recent Developments
11.12 Debiopharm
11.12.1 Debiopharm Corporation Information
11.12.2 Debiopharm Overview
11.12.3 Debiopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Debiopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Debiopharm Recent Developments
11.13 Alza
11.13.1 Alza Corporation Information
11.13.2 Alza Overview
11.13.3 Alza Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Alza Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Alza Recent Developments
11.14 CordenPharma
11.14.1 CordenPharma Corporation Information
11.14.2 CordenPharma Overview
11.14.3 CordenPharma Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CordenPharma Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CordenPharma Recent Developments
11.15 Pharmascience
11.15.1 Pharmascience Corporation Information
11.15.2 Pharmascience Overview
11.15.3 Pharmascience Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Pharmascience Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pharmascience Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Injection Drug Industry Chain Analysis
12.2 Oncology Injection Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Injection Drug Production Mode & Process
12.4 Oncology Injection Drug Sales and Marketing
12.4.1 Oncology Injection Drug Sales Channels
12.4.2 Oncology Injection Drug Distributors
12.5 Oncology Injection Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology Injection Drug Industry Trends
13.2 Oncology Injection Drug Market Drivers
13.3 Oncology Injection Drug Market Challenges
13.4 Oncology Injection Drug Market Restraints
14 Key Findings in The Global Oncology Injection Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Oncology Injection Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Organs
    Table 3. Major Manufacturers of Central Nervous System
    Table 4. Major Manufacturers of Circulatory/Musculoskeletal System
    Table 5. Major Manufacturers of Other
    Table 6. Global Oncology Injection Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Oncology Injection Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Oncology Injection Drug Sales by Region (2017-2022) & (K Pcs)
    Table 9. Global Oncology Injection Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Oncology Injection Drug Sales by Region (2023-2028) & (K Pcs)
    Table 11. Global Oncology Injection Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Oncology Injection Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Oncology Injection Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Oncology Injection Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Oncology Injection Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Oncology Injection Drug Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 17. Global Oncology Injection Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Oncology Injection Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Oncology Injection Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Oncology Injection Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 21. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2021)
    Table 23. Oncology Injection Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Oncology Injection Drug Product Offered
    Table 25. Date of Manufacturers Enter into Oncology Injection Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 28. Global Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 29. Global Oncology Injection Drug Sales Share by Type (2017-2022)
    Table 30. Global Oncology Injection Drug Sales Share by Type (2023-2028)
    Table 31. Global Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Oncology Injection Drug Revenue Share by Type (2017-2022)
    Table 34. Global Oncology Injection Drug Revenue Share by Type (2023-2028)
    Table 35. Oncology Injection Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 36. Global Oncology Injection Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 37. Global Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 38. Global Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 39. Global Oncology Injection Drug Sales Share by Application (2017-2022)
    Table 40. Global Oncology Injection Drug Sales Share by Application (2023-2028)
    Table 41. Global Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Oncology Injection Drug Revenue Share by Application (2017-2022)
    Table 44. Global Oncology Injection Drug Revenue Share by Application (2023-2028)
    Table 45. Oncology Injection Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 46. Global Oncology Injection Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 47. North America Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 48. North America Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 49. North America Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 52. North America Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 53. North America Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)
    Table 56. North America Oncology Injection Drug Sales by Country (2023-2028) & (K Pcs)
    Table 57. North America Oncology Injection Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Oncology Injection Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 61. Europe Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 64. Europe Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 65. Europe Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)
    Table 68. Europe Oncology Injection Drug Sales by Country (2023-2028) & (K Pcs)
    Table 69. Europe Oncology Injection Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Oncology Injection Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 72. Asia Pacific Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 73. Asia Pacific Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 76. Asia Pacific Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 77. Asia Pacific Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Oncology Injection Drug Sales by Region (2017-2022) & (K Pcs)
    Table 80. Asia Pacific Oncology Injection Drug Sales by Region (2023-2028) & (K Pcs)
    Table 81. Asia Pacific Oncology Injection Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Oncology Injection Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 84. Latin America Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 85. Latin America Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 88. Latin America Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 89. Latin America Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)
    Table 92. Latin America Oncology Injection Drug Sales by Country (2023-2028) & (K Pcs)
    Table 93. Latin America Oncology Injection Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Oncology Injection Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)
    Table 96. Middle East and Africa Oncology Injection Drug Sales by Type (2023-2028) & (K Pcs)
    Table 97. Middle East and Africa Oncology Injection Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Oncology Injection Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)
    Table 100. Middle East and Africa Oncology Injection Drug Sales by Application (2023-2028) & (K Pcs)
    Table 101. Middle East and Africa Oncology Injection Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Oncology Injection Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)
    Table 104. Middle East and Africa Oncology Injection Drug Sales by Country (2023-2028) & (K Pcs)
    Table 105. Middle East and Africa Oncology Injection Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Oncology Injection Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Taj Oncology Corporation Information
    Table 108. Taj Oncology Description and Major Businesses
    Table 109. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Taj Oncology Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Taj Oncology Recent Developments
    Table 112. S.G. Biopharm Corporation Information
    Table 113. S.G. Biopharm Description and Major Businesses
    Table 114. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. S.G. Biopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. S.G. Biopharm Recent Developments
    Table 117. AdvaCare Corporation Information
    Table 118. AdvaCare Description and Major Businesses
    Table 119. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. AdvaCare Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. AdvaCare Recent Developments
    Table 122. Merrimack Corporation Information
    Table 123. Merrimack Description and Major Businesses
    Table 124. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Merrimack Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Merrimack Recent Developments
    Table 127. Celgene Corporation Information
    Table 128. Celgene Description and Major Businesses
    Table 129. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 130. Celgene Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Celgene Recent Developments
    Table 132. Allos Therapeutics Corporation Information
    Table 133. Allos Therapeutics Description and Major Businesses
    Table 134. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 135. Allos Therapeutics Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Allos Therapeutics Recent Developments
    Table 137. Ferring Pharmaceuticals Corporation Information
    Table 138. Ferring Pharmaceuticals Description and Major Businesses
    Table 139. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 140. Ferring Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Ferring Pharmaceuticals Recent Developments
    Table 142. Genzyme Corporation Information
    Table 143. Genzyme Description and Major Businesses
    Table 144. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 145. Genzyme Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Genzyme Recent Developments
    Table 147. Eli Lilly Corporation Information
    Table 148. Eli Lilly Description and Major Businesses
    Table 149. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 150. Eli Lilly Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Eli Lilly Recent Developments
    Table 152. Praecis Pharmaceuticals Corporation Information
    Table 153. Praecis Pharmaceuticals Description and Major Businesses
    Table 154. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 155. Praecis Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Praecis Pharmaceuticals Recent Developments
    Table 157. Millennium Pharmaceuticals Corporation Information
    Table 158. Millennium Pharmaceuticals Description and Major Businesses
    Table 159. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 160. Millennium Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Millennium Pharmaceuticals Recent Developments
    Table 162. Debiopharm Corporation Information
    Table 163. Debiopharm Description and Major Businesses
    Table 164. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 165. Debiopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Debiopharm Recent Developments
    Table 167. Alza Corporation Information
    Table 168. Alza Description and Major Businesses
    Table 169. Alza Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 170. Alza Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Alza Recent Developments
    Table 172. CordenPharma Corporation Information
    Table 173. CordenPharma Description and Major Businesses
    Table 174. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 175. CordenPharma Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. CordenPharma Recent Developments
    Table 177. Pharmascience Corporation Information
    Table 178. Pharmascience Description and Major Businesses
    Table 179. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 180. Pharmascience Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Pharmascience Recent Developments
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Oncology Injection Drug Distributors List
    Table 185. Oncology Injection Drug Customers List
    Table 186. Oncology Injection Drug Market Trends
    Table 187. Oncology Injection Drug Market Drivers
    Table 188. Oncology Injection Drug Market Challenges
    Table 189. Oncology Injection Drug Market Restraints
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology Injection Drug Product Picture
    Figure 3. Global Oncology Injection Drug Market Share by Type in 2021 & 2028
    Figure 3. Organs Product Picture
    Figure 4. Central Nervous System Product Picture
    Figure 5. Circulatory/Musculoskeletal System Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Oncology Injection Drug Market Share by Application in 2021 & 2028
    Figure 8. Lymphoma
    Figure 9. Myeloma
    Figure 10. Prostate Cancer
    Figure 11. Other
    Figure 12. Oncology Injection Drug Report Years Considered
    Figure 13. Global Oncology Injection Drug Sales 2017-2028 (K Pcs)
    Figure 14. Global Oncology Injection Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Oncology Injection Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Oncology Injection Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Oncology Injection Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Oncology Injection Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Oncology Injection Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America Oncology Injection Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Oncology Injection Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe Oncology Injection Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Oncology Injection Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific Oncology Injection Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Oncology Injection Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America Oncology Injection Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Oncology Injection Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa Oncology Injection Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Oncology Injection Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Oncology Injection Drug in the World: Market Share by Oncology Injection Drug Revenue in 2021
    Figure 31. Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 35. Global Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 36. North America Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 39. North America Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 40. North America Oncology Injection Drug Sales Share by Country (2017-2028)
    Figure 41. North America Oncology Injection Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 47. Europe Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Oncology Injection Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Oncology Injection Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Oncology Injection Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Oncology Injection Drug Revenue Share by Region (2017-2028)
    Figure 61. China Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Oncology Injection Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Oncology Injection Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Oncology Injection Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Oncology Injection Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Oncology Injection Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Oncology Injection Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Oncology Injection Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Oncology Injection Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Oncology Injection Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Oncology Injection Drug Value Chain
    Figure 90. Oncology Injection Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Granisetron Hydrochloride API Market Insights Forecast to 2028
Global Granisetron Hydrochloride API Market Insights, Forecast to 2028

It is a raw material for nervous system and is used in the production of Tropisetron Hydrochloride.Market Analysis and Insights Global Granisetron Hydrochloride API MarketDue to the COVID19 pandemic the global Granisetron Hydrochloride API market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-35O10206
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Lab Scale Bioreactor Market Insights Forecast to 2028
Global Lab Scale Bioreactor Market Insights, Forecast to 2028

The small volume bioreactors enable the biomass growth extracellular metabolite production solidstate fermentation and biocatalytic processes in a controlled open system.Market Analysis and Insights Global Lab Scale Bioreactor MarketDue to the COVID19 pandemic the global Lab Scale Bioreactor market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-17O10483
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Ocular Excipients Market Insights Forecast to 2028
Global Ocular Excipients Market Insights, Forecast to 2028

Market Analysis and Insights Global Ocular Excipients MarketDue to the COVID19 pandemic the global Ocular Excipients market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2T10675
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Barium Titanium Oxide Market Insights Forecast to 2028
Global Barium Titanium Oxide Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9Z7409
Wed May 18 00:00:00 UTC 2022

Add to Cart